Stimulating the Social Brain

NCT ID: NCT03374631

Last Updated: 2023-03-22

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-12-01

Study Completion Date

2020-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study investigates whether the way in which individuals process social stimuli can be altered, and specifically, whether feelings of paranoia and suspiciousness can be reduced by stimulating the brain's regulatory regions via transcranial Direct Current Stimulation (tDCS).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Although paranoid ideation is typically associated with severe mental illnesses such as schizophrenia or bipolar disorder, 10-15% of individuals in the general population report experiencing paranoid thoughts on a regular basis. These individuals who are high in sub-clinical paranoia can show impaired work and social functioning as compared to individuals low in sub-clinical paranoia. The wide spread prevalence and negative functional impact of heightened paranoia reinforces the need to develop interventions that may help to reduce problematic patterns of paranoid thinking in both healthy individuals and those with mental illness.

Transcranial Direct Current Stimulation (tDCS) is a form of noninvasive neurostimulation which has been proposed as a therapeutic procedure in numerous psychiatric conditions. TDCS therefore may be a promising therapeutic technique for reducing symptoms of psychosis, and specifically paranoia. This study will compare experiences of paranoid ideation in individuals who are high in sub-clinical paranoia across two conditions: active anodal tDCS and sham tDCS.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Adults

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Participants will complete active and sham simulation sessions in a randomized, counterbalanced order approximately one week apart.
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Active anodal tDCS, Then Sham tDCS

Active anodal tDCS followed by behavioral testing; one week later, sham tDCS followed by behavioral testing

Group Type EXPERIMENTAL

active anodal tDCS

Intervention Type DEVICE

active anodal tDCS with behavioral tasks and self-report measures to assess paranoid ideation

sham tDCS

Intervention Type DEVICE

sham tDCS with behavioral tasks and self-report measures to assess paranoid ideation

Sham tDCS, then Active anodal tDCS

Sham tDCS followed by behavioral testing; one week later, active anodal tDCS followed by behavioral testing.

Group Type SHAM_COMPARATOR

active anodal tDCS

Intervention Type DEVICE

active anodal tDCS with behavioral tasks and self-report measures to assess paranoid ideation

sham tDCS

Intervention Type DEVICE

sham tDCS with behavioral tasks and self-report measures to assess paranoid ideation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

active anodal tDCS

active anodal tDCS with behavioral tasks and self-report measures to assess paranoid ideation

Intervention Type DEVICE

sham tDCS

sham tDCS with behavioral tasks and self-report measures to assess paranoid ideation

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* between the ages of 18 ad 35
* previous classification as being high in sub-clinical paranoia

Exclusion Criteria

* diagnosis of mental illness
* use of psychotropic medication
* Presence or history of medical, cardiac, or neurological disorders that may affect brain function (e.g., cardiac disease, endocrine disorders, renal disease, pulmonary disease, history of seizures or head trauma with unconsciousness for a period of 15 minutes or greater or CNS tumors)
* Presence of sensory limitation including visual (e.g., blindness, glaucoma, vision uncorrectable to 20/40) or hearing (e.g. hearing loss) impairments that interfere with assessment
* Not proficient in English
* Contraindications for tDCS (e.g., pregnancy or implanted devices such as pace maker)
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The University of Texas at Dallas

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Amy Pinkham, PhD

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Amy Pinkham, PhD

Role: PRINCIPAL_INVESTIGATOR

The University of Texas at Dallas

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Unversity of Texas at Dallas

Richardson, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17-126

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.